More promising Golden Triangle drill results sparked much speculation in shares of a junior explorer Wednesday. Here’s some small stocks making big moves on Wednesday, October 10, 2018 (as of 4 pm EST):
GT Gold Corp. (TSXV:GTT) shares jumped 46% to $1.14 on Wednesday after the junior explorer announced assay results for the latest holes from the Saddle North target on its wholly-owned Tatogga property in the Golden Triangle district of British Columbia, which included 363 metres of 1.02 g/t gold, 0.51% copper, 1.72 g/t silver.
As well, shares of BlackPearl Resources Inc. (TSX:PXX) rose 9% to $1.41 as the heavy oil and natural gas company said it has agreed to be acquired by International Petroleum Corp. (TSX:IPCO) in all-stock transaction. BlackPearl shareholders will receive 0.22 shares of IPC for each BlackPearl share held.
Neovasc Inc. (TSX:NVCN), meanwhile, reported that the U.S. Food and Drug Administration has granted Breakthrough Device designation to the Neovasc Reducer, a medical device for the treatment of refractory angina, which is not currently approved for commercial sale in the United States. Neovasc stock popped 13% to $3.57 following the announcement.
Finally, Theralase Technologies Inc. (TSXV:TLT) shares gained 13% to $0.34 after the clinical-stage pharmaceutical company announced that Theralase affiliated researchers have presented immunohistochemical analytical data supporting the use of TLD-1433 Photo Dynamic Therapy in the destruction of gastrointestinal dysplasia and esophageal cancer.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.